The authors thank all the centres that participated in this study: Institute G. Gaslini Genova, Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway, Department of Hematology, Rennes University Hospital, Rennes, France, Comenius University Medical School, Limbová, Bratislava, Slovak Republic, Paediatric Team Children’s BMT Unit Great North Children’s Hospital Newcastle-Upon-Tyne, Division of Stem Cell Transplantation, Children’s Research Center (CRC), University Children’s Hospital, Zurich, Switzerland, Department of Hematology, Reina Sofia Hospital, Cordoba, Spain, Department of Pediatric Oncology, Sahlgrenska University Hospital, Gothenburg i, Sweden, American University of Beirut Medical Center, Department of Pediatric Hemato-Oncology and Stem Cells Transplant, Universitair Ziekenhuis Ghent, Ghent, Belgium, Hôpital Huriez UAM allo-CSH Lille, Istituto per l’Infanzia “IRCCS Burlo Garofolo” Centro Trapianti Clinica Pediatrica Trieste, Italy, Department of Hematology, Nancy CHU, UTMA, Vandoeuvre-lès-Nancy, France, King Hussein Cancer Center, Sweileh, Jordan, University Children’s Hospital in Krakow Department of Transplantation, Krakow, Poland, Hopital Charles Nicolle Pediatrie et Genetique Medicale Rouen, France, United St. Istvan and St. Laszlo Hospital Department of Pediatric Hematology and Stem Cell Transplantation Budapest, The Russian Children’s Research Hospital Department Bone Marrow Transplantation Moscow, Russia, University Hospital BMT Centre Leiden, Centre Hospitalier Universitaire Sainte-Justine Centre de Cancérologie Charles-Bruneau Montréal, Hopital St. Louis Paris Department of Hematology, Policlinico G.B. Rossi Paediatric Haematology Oncology Verona, University Hospital Eppendorf Bone Marrow Transplantation Centre Hamburg, University Hospital Center Rebro Zagreb, Akdeniz University Medical School Department of Pediatric Hematology Antalya, Hematology and Transplantation, University of Liege, CHU Timone Enfants Marseille, Sheffield Teaching Hospitals NHS Trust, Hopital Jean Minjoz Service d’Hématologie Besancon, Institut Jules Bordet Experimental Hematology Brussels, Karolinska University Hospital Children’s Hospital Paediatric Haematology Stockholm, University of Jena Department of Pediatrics, The Children’s Hospital at Westmead, Sydney, Australia, Centre Pierre et Marie Curie, Alger, Algeria, Leeds Teaching Hospitals, CHU Gabriel-Montpied, Clermont-Ferrand, Children’s University Hospital Department Pediatric Hematology, Oncology, and Transplantology Lublin, University La Sapienza Dip. Biotecnologie Cellulari ed Ematologia Rome, University of Helsinki Hospital for Children and Adolescents, Gazi University Ankara Turkey, University Hospital Leuven, Instituto Portugues de Oncologia, Lisbon, University Medical Centre Ljubljana, University College London Hospital Department of Haematology, CHU Nantes Department D’Hematologie, H Sirio-Libanes Sao Paulo, Medical University Wroclaw, Baskent University Hospital Haematology Division BMT Unit Yuregir Adana, University Children’s Hospital of Basel, Bristol Royal Hospital for Children Department of Paediatric Oncology/BMT, Collegium Medicum UMK Pediatric Hematology and Oncology Bydgoszcz, Ospedale Oncologico A. Businco, Cagligari, University of Cape Town Faculty of Health Sciences, Cape Town, South Africa, Universitaetsklinikum Dresden Medizinische Klinik und Poliklinik I, Royal Hospital for Sick Children Department of Haematology Glasgow, CHU Grenoble Alpes, Acibadem University Atakent Hospital Pediatric BMT Unit Istanbul, Belorussian Centre for Paediatric Oncology and Hematology Minsk, Hospital Universitario Virgen de la Arrixaca Murcia, Hospital Universitari Son Espases Hematology Service Palma De Mallorca, Fondazione IRCCS Policlinico San Matteo Pediatric Hematology-Oncology Pavia, University Hospital La Fe, Valencia, Hospital Santa Creu i Sant Pau Department of Pediatrics Barcelona, CHU de Montpellier, Pediatric Oncology-Hematology Unit, Santa Maria della Misericordia Hospital, Perugia, First Soochow Hospital Suzhou, Hospital Clinico Universitario de Valencia, Vilnius University Hospital Santaros Klinikos.
Trending
- The Power of Waiting When You Don’t Know What to Do
- Low-fat dietary pattern and dietary advanced glycation end-products intake: a secondary analysis of the Women’s Health Initiative randomized trial
- Johnson & Johnson Proposes $5.5 Billion Talc Settlement to End Marathon Legal Fight
- Mechanism-of-Action Switching and Treatment Selection After Progression in CLL
- FDA staff reiterate concerns about Replimmune skin cancer treatment
- Developing A Precision Approach to CAR T-Cell Toxicity Management
- RP1’s Long Road: A Timeline of RP1’s Regulatory Journey in Advanced Melanoma
- Case Discussion: Treatment-Naïve Patient with CLL with Unmutated IGHV

